 CANTON, Mass., Jan. 13, 2021 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical Sports Medicine markets, today reported preliminary financial results for the three months and twelve months ended December 31, 2020. 